Signal Transduction and Targeted Therapy (May 2024)

Structural basis of negative regulation of CRISPR-Cas7-11 by TPR-CHAT

  • Tian Hong,
  • Qinghua Luo,
  • Haiyun Ma,
  • Xin Wang,
  • Xinqiong Li,
  • Chongrong Shen,
  • Jie Pang,
  • Yan Wang,
  • Yuejia Chen,
  • Changbin Zhang,
  • Zhaoming Su,
  • Haohao Dong,
  • Xiaodi Tang

DOI
https://doi.org/10.1038/s41392-024-01821-4
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 10

Abstract

Read online

Abstract CRISPR‒Cas7-11 is a Type III-E CRISPR-associated nuclease that functions as a potent RNA editing tool. Tetratrico-peptide repeat fused with Cas/HEF1-associated signal transducer (TPR-CHAT) acts as a regulatory protein that interacts with CRISPR RNA (crRNA)-bound Cas7-11 to form a CRISPR-guided caspase complex (Craspase). However, the precise modulation of Cas7-11’s nuclease activity by TPR-CHAT to enhance its utility requires further study. Here, we report cryo-electron microscopy (cryo-EM) structures of Desulfonema ishimotonii (Di) Cas7-11-crRNA, complexed with or without the full length or the N-terminus of TPR-CHAT. These structures unveil the molecular features of the Craspase complex. Structural analysis, combined with in vitro nuclease assay and electrophoretic mobility shift assay, reveals that DiTPR-CHAT negatively regulates the activity of DiCas7-11 by preventing target RNA from binding through the N-terminal 65 amino acids of DiTPR-CHAT (DiTPR-CHATNTD). Our work demonstrates that DiTPR-CHATNTD can function as a small unit of DiCas7-11 regulator, potentially enabling safe applications to prevent overcutting and off-target effects of the CRISPR‒Cas7-11 system.